Literature DB >> 19166685

Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.

Stanley Chia1, John T Nagurney, David F M Brown, O Christopher Raffel, Fabian Bamberg, Fred Senatore, Frans J Th Wackers, Ik-Kyung Jang.   

Abstract

Elevated leukocyte count during ST-segment elevation myocardial infarction is associated with adverse clinical outcomes. Whether increased leukocyte count after primary percutaneous coronary intervention (PCI) directly reflects larger infarct size and left ventricular impairment is not known. The aim of this study was to assess the relation between leukocyte and neutrophil counts with infarct size and the left ventricular ejection fraction (LVEF) after primary PCI. Three hundred sixty-three patients from the Evaluation of MCC-135 for Left Ventricular Salvage in Acute Myocardial Infarction (EVOLVE) study, a randomized, double-blind, placebo-controlled trial assessing the efficacy of intracellular calcium modulator as an adjunct to primary PCI in patients with first ST-segment elevation myocardial infarctions, were evaluated. Total and differential leukocyte counts were measured before and serially after PCI. Infarct size and the LVEF were assessed using single-photon emission computed tomography after 5 and 30 days, and patients were followed up to 180 days. Total leukocyte and neutrophil counts obtained 24 hours after PCI were significantly correlated with infarct size (r = 0.34 and 0.37, respectively, p <0.001) and inversely correlated with the LVEF (r = -0.20 and -0.22, respectively, p <0.001). Patients with elevated leukocyte and neutrophil counts had larger infarct sizes (12.5% vs 5% and 13.5% vs 5%, respectively, p <0.001). The highest neutrophil quartile was associated with increased 180-day composite cardiac events (19% vs 20% vs 23% vs 45%, log-rank p <0.001). Elevated leukocyte and neutrophil counts independently predicted adverse cardiac events (hazard ratios 2.5 and 2.2, respectively, p = 0.001). In conclusion, elevated leukocyte and neutrophil counts after primary PCI in patients with ST-segment elevation myocardial infarctions are directly related to myocardial infarct size and the LVEF and are independent predictors of cardiovascular outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 19166685     DOI: 10.1016/j.amjcard.2008.09.085

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  53 in total

Review 1.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

2.  Aminobenzoic acid hydrazide, a myeloperoxidase inhibitor, alters the adhesive properties of neutrophils isolated from acute myocardial infarction patients.

Authors:  Lili Han; Xiaoli Shen; Leng Pan; Saimei Lin; Xiaoqing Liu; Yulian Deng; Xiaodong Pu
Journal:  Heart Vessels       Date:  2011-08-12       Impact factor: 2.037

3.  The role of nitric oxide in regulation of leukocyte migration into the heart tissue in vitro.

Authors:  A A Petenkova; R I Kovalenko; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2016-01-05

4.  Trajectories of Circulating Monocyte Subsets After ST-Elevation Myocardial Infarction During Hospitalization: Latent Class Growth Modeling for High-Risk Patient Identification.

Authors:  Shan Zeng; Li-Fang Yan; Yan-Wei Luo; Xin-Lin Liu; Jun-Xiang Liu; Zhao-Zeng Guo; Zhong-Wei Xu; Yu-Ming Li; Wen-Jie Ji; Xin Zhou
Journal:  J Cardiovasc Transl Res       Date:  2018-01-08       Impact factor: 4.132

5.  Neutrophil-to-lymphocyte ratio (NLR) predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people.

Authors:  Jingyu He; Jing Li; Yunfei Wang; Peng Hao; Qi Hua
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Acute myocardial infarct size is related to periodontitis extent and severity.

Authors:  R Marfil-Álvarez; F Mesa; A Arrebola-Moreno; J A Ramírez-Hernández; A Magán-Fernández; F O'Valle; P Galindo-Moreno; A Catena
Journal:  J Dent Res       Date:  2014-08-19       Impact factor: 6.116

7.  IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells.

Authors:  Andre Heinen; Rianne Nederlof; Priyadarshini Panjwani; André Spychala; Tengis Tschaidse; Heiko Reffelt; Johannes Boy; Annika Raupach; Stefanie Gödecke; Patrick Petzsch; Karl Köhrer; Maria Grandoch; Anne Petz; Jens W Fischer; Christina Alter; Jelena Vasilevska; Philipp Lang; Axel Gödecke
Journal:  Mol Ther       Date:  2018-11-01       Impact factor: 11.454

Review 8.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

9.  BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.

Authors:  Lehanna N Sanders; John A Schoenhard; Mohamed A Saleh; Amrita Mukherjee; Sergey Ryzhov; William G McMaster; Kristof Nolan; Richard J Gumina; Thomas B Thompson; Mark A Magnuson; David G Harrison; Antonis K Hatzopoulos
Journal:  Circ Res       Date:  2016-06-09       Impact factor: 17.367

10.  Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction.

Authors:  Gopalkrishna Sreejit; Ahmed Abdel-Latif; Baskaran Athmanathan; Andrew J Murphy; Prabhakara R Nagareddy; Rahul Annabathula; Ashish Dhyani; Sunil K Noothi; Gregory A Quaife-Ryan; Annas Al-Sharea; Gerard Pernes; Dragana Dragoljevic; Hind Lal; Kate Schroder; Beatriz Y Hanaoka; Chander Raman; Maria B Grant; James E Hudson; Susan S Smyth; Enzo R Porrello
Journal:  Circulation       Date:  2020-01-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.